epigenetic brca2 gene in epithelial ovarian cancer
Authors
abstract
background ovarian cancer is the most common fatal gynecologic malignancy in women. the brca2 gene has a role in regulation of cell cycle during proliferation, differentiation and dna repair. changes in the methylation of brca2 may be an effective mechanism for ovarian cancer. objectives the aim of the present study was to evaluate the association between ovarian cancer and methylation status of brca2. materials and methods in this study, methylation changes of brca2 genes in 44 tissue samples from patients with ovarian cancer and 44 adjacent normal ovarian tissue samples were studied as the control group. after primer design and amplification of the brca2 gene sequence by the polymerase chain reaction (pcr), gene methylation levels were evaluated using an enzymatic digestion method, restriction fragment length polymorphism (rflp). results according to the study of the methylation status of subjects, status changes were observed only in three cases. the results did not show a correlation between brca2 gene promoter methylation in ovarian cancer patients and healthy subjects. conclusions according to the results obtained in this study, changes in the methylation status of brca2 cannot be the decisive factor to ascertain the development of ovarian cancer.
similar resources
promoter methylation status and protein expression of brca2 in patients with epithelial ovarian cancer
background : ovarian cancer is the leading cause of death among gynecological cancers. changes in the methylation of brca1 and brca2 may be an effective mechanism for breast and ovarian cancer. this study evaluates the protein expression and methylation status of brca2 in iranian patients. methods : we assessed 60 mullerian-type ovarian cancers by methylation-specific pcr assays and immunohisto...
full textBRCA2 N372H Polymorphism and Risk of Epithelial Ovarian Cancer
The BRCA2 N372H is the only common polymorphism that leads to the amino acid change based on the reports up to date. Previous studies explored the relationship between the single nucleotide polymorphism and ovarian cancer risk, but the results were inconsistent or inconclusive.To investigate the association between N372H in BRCA2 gene and ovarian cancer susceptibility, a systematic literature s...
full textEpigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Hypermethylation of the BRCA1 promoter has previously been shown to cause reduced mRNA expression in both breast and ovarian cancers. Nothing is yet known of the expression pattern or methylation status of the promoter region of BRCA2 in sporadic ovarian cancer. Whereas our analysis of 30 sporadic ovarian carcinomas showed a statistically significant reduction of BRCA1 mRNA expression (P = 0.00...
full textserum her2 level in epithelial ovarian cancer
introduction : the proto-oncogene her2 plays a key role in the control of cellular proliferation. its overexpression has been reported to be associated with a poor prognosis in cancer, particularly in breast cancer. materials and methods : in the present study, serum her2 levels were investigated in patients diagnosed with epithelial ovarian cancer. serum her2 levels were detected by an elisa c...
full textAssociation between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
CONTEXT Approximately 10% of women with invasive epithelial ovarian cancer (EOC) carry deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2-related EOC was associated with an improved prognosis, but the effect of BRCA1 remains unclear. OBJECTIVE To characterize the survival of BRCA carriers with EOC compared with noncarriers and to determine whether BRCA1 an...
full textPerturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer.
The majority of human high-grade serous epithelial ovarian cancer (SEOC) is characterized by frequent mutations in p53 and alterations in the RB and FOXM1 pathways. A subset of human SEOC harbors a combination of germline and somatic mutations as well as epigenetic dysfunction for BRCA1/2. Using Cre-conditional alleles and intrabursal induction by Cre-expressing adenovirus in genetically engine...
full textMy Resources
Save resource for easier access later
Journal title:
gene, cell and tissueجلد ۲، شماره ۲، صفحات ۰-۰
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023